Moreover, in comparison with the adjacent nontumorous samples, MMP9 and FAHD2P1 were enhanced in the BLCA samples, whereas IGF1 was reduced (Figures 10A–C, p < 0.01). This evidence concerns the gene MMP9 and bladder transitional cell carcinoma.